ACOD1-/- MSLN-CAR-iMACs expressed more pro-inflammatory marker proteins (CD80 and CD86) after being co-cultured with HO-8910 ovarian cancer cells for 24 h (Fig. 6a, b). This evidence concerns the gene CD86 and ovarian carcinoma.